Is OPKO Health efficiently growing its dividend?
OPKO Health does not have a long track record of dividend growth. In the past three months, OPKO Health insiders have not sold or bought any company stock. 41.47% of the stock of OPKO Health is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 27.51% of the stock of OPKO Health is held by institutions.
Do analysts agree on OPKO Health's (OPKO) price targets?
The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $6.00, OPKO Health has a forecasted upside of 24.2% from its current price of $4.83.
Is OPKO Health (OPK) forming a JV?
OPKO Health (OPK) Forms JV, Establishes Presence in China Sep. 15, 2021 at 9:39 a.m. ETon Zacks.com Hancock Horizon Burkenroad Small Cap Fund Buys Earthstone Energy Inc, Waitr Holdings Inc, OPKO ... Sep. 4, 2021 at 2:38 a.m. ETon GuruFocus.com Colony Family Offices, LLC Buys Dimensional U.S. ...
What does OPKO Health Inc do?
OPKO Health Inc. OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations.
See more
Is OPK stock a good buy?
Is Opko Health Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OPK) stock is to Buy OPK stock.
What is Opk new price target?
Stock Price Target OPKHigh$8.50Median$6.25Low$5.00Average$6.50Current Price$2.58
Does opko stock pay a dividend?
OPKO Health, Inc. has not declared or paid cash dividends. The company has retained earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
Will OPK go up?
OPKO Health Inc (NASDAQ:OPK) The 4 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 6.25, with a high estimate of 8.50 and a low estimate of 5.00. The median estimate represents a +138.55% increase from the last price of 2.62.
What does opko Health do?
OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
Who owns opko health company?
Dr. Phillip FrostAt OPKO Health, the entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs.
Is Xela Stock good?
The financial health and growth prospects of XELA, demonstrate its potential to underperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
How much does Opko Health make?
What is the P/B ratio of Opko Health?
OPKO Health has a market capitalization of $2.36 billion and generates $1.44 billion in revenue each year. The biotechnology company earns $30.59 million in net income (profit) each year or $0.05 on an earnings per share basis.
What is Opko Health?
OPKO Health has a P/B Ratio of 1.64. P /B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
Is Opko Health a buy?
OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Does Opko pay dividends?
OPKO Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
What is Opko Health?
OPKO Health does not currently pay a dividend.
What time do you trade in the pre market?
Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business
What is market cap?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
Who owns restricted shares of a company?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
How to calculate P/E?
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Business
Risks
- 2 equities research analysts have issued 1-year target prices for Opko Health's stock. Their predictions range from $5.00 to $20.00. On average, they anticipate Opko Health's share price to reach $12.50 in the next year. This suggests a possible upside of 489.6% from the stock's current price. View Analyst Price Targets for Opko Health.
Ratings
- 2 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Opko Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Opko Health.
Reception
- Headlines about OPK stock have trended neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Opko Health e…
Ownership
- Opko Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.90%), Dimensional Fund Advisors LP (0.70%), Wells Fargo & Company MN (0.24%), RK Asset Management LLC (0.19%), Fosun International Ltd (0.14%) and Pictet Asset Management Ltd. (0.11%). Company insiders that own Opko Health stock include A…
Operations
- Opko Health has a market capitalization of $1.31 billion and generates $990.30 million in revenue each year. The biotechnology company earns $-153,040,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Opko Health employs 5,690 workers across the globe.
Access
- Opko Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at 305-575-4100 or via email at [email protected].